Tag: ACC

ACC.21: VOYAGER PAD shows rivaroxaban ‘significantly’ reduced total ischemic events in...

Rivaroxaban combined with low-dose aspirin led to a significant reduction in the occurrence of total ischemic events in patients with symptomatic peripheral arterial disease...

SVS, ACC complete move to single vascular registry

The Society for Vascular Surgery (SVS) and the American College of Cardiology (ACC) have completed a move to create a single vascular registry. The new...

‘Ample published data unable to replicate association between paclitaxel-coated devices and...

Ample published data from from large, observational datasets, randomized-controlled trial (RCT) subgroup analyses and long-term follow-up from pivotal paclitaxel-coated device RCTs have not been...

ACC, SVS join forces on single vascular registry

The American College of Cardiology (ACC) and Society for Vascular Surgery (SVS) are collaborating on a single vascular registry to harness the strengths of...

Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularization

Treatment with aspirin plus rivaroxaban following lower-extremity revascularization in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of...